Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Cancer Cell

Volumn 17, Issue 1, 2010, Pages 98-110

  Verhaak, Roel G W ^a,b   Hoadley, Katherine A ^c,d   Purdom, Elizabeth ^e   Wang, Victoria ^e   Qi, Yuan ^c,d   Wilkerson, Matthew D ^c,d   Miller, C Ryan ^c,d   Ding, Li ^f   Golub, Todd ^a,b   Mesirov, Jill P ^a   Alexe, Gabriele ^a   Lawrence, Michael ^a,b   O'Kelly, Michael ^a,b   Tamayo, Pablo ^a   Weir, Barbara A ^a,b   Gabriel, Stacey ^a   Winckler, Wendy ^a,b   Gupta, Supriya ^a   Jakkula, Lakshmi ^g   Feiler, Heidi S ^g   Hodgson, J Graeme ^h   James, C David ^h   Sarkaria, Jann N ⁱ   Brennan, Cameron ^j   Kahn, Ari ^k   Spellman, Paul T ^g   Wilson, Richard K ^f   Speed, Terence P ^e,l   Gray, Joe W ^g   Meyerson, Matthew ^a,b   Getz, Gad ^a   Perou, Charles M ^c,d,e   Hayes, D Neil ^c,d   more..

^a HARVARD UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ MAYO CLINIC   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k GENERAL DYNAMICS   (United States)

^l Institute   (Australia)

more..

Author keywords

CELLCYCLE

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOCITRATE DEHYDROGENASE; NEUROFIBROMIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ARTICLE; BRAIN CELL; CANCER CLASSIFICATION; CELL LINEAGE; CELL TYPE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOMICS; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYME; PRIORITY JOURNAL; SOMATIC MUTATION; TRANSCRIPTOMICS; TREATMENT RESPONSE;

EID: 73649123907     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.12.020     Document Type: Article

References (49)

1. Arjona D., Rey J.A., and Taylor S.M. Early genetic changes involved in low-grade astrocytic tumor development. Curr. Mol. Med. 6 (2006) 645-650
2. Barbie D.A., Tamayo P., Boehm J.S., Kim S.Y., Moody S.E., Dunn I.F., Schinzel A.C., Sandy P., Meylan E., Scholl S., et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462 (2009) 108-112
3. Beroukhim R., Getz G., Nghiemphu L., Barretina J., Hsueh T., Linhart D., Vivanco I., Lee J.C., Huang J.H., Alexander S., et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA 104 (2007) 20007-20012
4. Brennan C., Momota H., Hambardzumyan D., Ozawa T., Tandon A., Pedraza A., and Holland E. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS ONE 4 (2009) e7752
5. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28 (2008) 264-278
6. Curran Jr. W.J., Scott C.B., Horton J., Nelson J.S., Weinstein A.S., Fischbach A.J., Chang C.H., Rotman M., Asbell S.O., Krisch R.E., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl. Cancer Inst. 85 (1993) 704-710
7. Dabney A.R. ClaNC: point-and-click software for classifying microarrays to nearest centroids. Bioinformatics 22 (2006) 122-123
8. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4 (2003) P3
9. Freije W.A., Castro-Vargas F.E., Fang Z., Horvath S., Cloughesy T., Liau L.M., Mischel P.S., and Nelson S.F. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64 (2004) 6503-6510
10. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., Hahn W.C., Ligon K.L., Louis D.N., Brennan C., et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21 (2007) 2683-2710
11. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., and Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64 (2004) 7011-7021
12. Hegi M.E., Diserens A.C., Gorlia T., Hamou M.F., de Tribolet N., Weller M., Kros J.M., Hainfellner J.A., Mason W., Mariani L., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352 (2005) 997-1003
13. Hodgson J.G., Yeh R.F., Ray A., Wang N.J., Smirnov I., Yu M., Hariono S., Silber J., Feiler H.S., Gray J.W., et al. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro. Oncol. 11 (2009) 477-487
14. Huber W., and Gentleman R. Matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements. Bioinformatics 20 (2004) 1651-1652
15. Hunter C., Smith R., Cahill D.P., Stephens P., Stevens C., Teague J., Greenman C., Edkins S., Bignell G., Davies H., et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res. 66 (2006) 3987-3991
16. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., and Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31 (2003) e15
17. Jackson E.L., Garcia-Verdugo J.M., Gil-Perotin S., Roy M., Quinones-Hinojosa A., VandenBerg S., and Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51 (2006) 187-199
18. Kleihues P., and Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol. 1 (1999) 44-51
19. Kreth F.W., Berlis A., Spiropoulou V., Faist M., Scheremet R., Rossner R., Volk B., and Ostertag C.B. The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86 (1999) 2117-2123
20. Kumabe T., Sohma Y., Kayama T., Yoshimoto T., and Yamamoto T. Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene 7 (1992) 627-633
21. Liang Y., Diehn M., Watson N., Bollen A.W., Aldape K.D., Nicholas M.K., Lamborn K.R., Berger M.S., Botstein D., Brown P.O., and Israel M.A. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc. Natl. Acad. Sci. USA 102 (2005) 5814-5819
22. Ligon K.L., Huillard E., Mehta S., Kesari S., Liu H., Alberta J.A., Bachoo R.M., Kane M., Louis D.N., Depinho R.A., et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53 (2007) 503-517
23. Liu H., Zeeberg B.R., Qu G., Koru A.G., Ferrucci A., Kahn A., Ryan M.C., Nuhanovic A., Munson P.J., Reinhold W.C., et al. AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets. Bioinformatics 23 (2007) 2385-2390
24. Liu Y., Hayes D.N., Nobel A., and Marron J. Statistical significance of clustering for high dimension low sample size data. J. Am. Stat. Assoc. 103 (2008) 1281-1293
25. Mardia K.V., Kent J.T., and Bibby J.M. Multivariate Analysis (1979), Academic Press, London
26. Mischel P.S., Shai R., Shi T., Horvath S., Lu K.V., Choe G., Seligson D., Kremen T.J., Palotie A., Liau L.M., et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22 (2003) 2361-2373
27. Monti S., Tamayo P., Mesirov J., and Golub T.R. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52 (2003) 91-118
28. Murat A., Migliavacca E., Gorlia T., Lambiv W.L., Shay T., Hamou M.F., de Tribolet N., Regli L., Wick W., Kouwenhoven M.C., et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J. Clin. Oncol. 26 (2008) 3015-3024
29. Noble M., Proschel C., and Mayer-Proschel M. Getting a GR(i)P on oligodendrocyte development. Dev. Biol. 265 (2004) 33-52
30. Nutt C.L., Mani D.R., Betensky R.A., Tamayo P., Cairncross J.G., Ladd C., Pohl U., Hartmann C., McLaughlin M.E., Batchelor T.T., et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 63 (2003) 1602-1607
31. Ohgaki H., and Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 109 (2005) 93-108
32. Olshen A.B., Venkatraman E.S., Lucito R., and Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5 (2004) 557-572
33. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., Misra A., Nigro J.M., Colman H., Soroceanu L., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9 (2006) 157-173
34. R Development Core Team. R: A language and environment for statistical computing (2008), R Foundation for Statistical Computing, Vienna, Austria
35. Rand V., Huang J., Stockwell T., Ferriera S., Buzko O., Levy S., Busam D., Li K., Edwards J.B., Eberhart C., et al. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc. Natl. Acad. Sci. USA 102 (2005) 14344-14349
36. Rousseeuw P.J. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20 (1987) 53-65
37. Ruano Y., Mollejo M., Ribalta T., Fiano C., Camacho F.I., Gomez E., de Lope A.R., Hernandez-Moneo J.L., Martinez P., and Melendez B. Identification of novel candidate target genes in amplicons of glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol. Cancer 5 (2006) 39
38. Sanai N., Alvarez-Buylla A., and Berger M.S. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353 (2005) 811-822
39. Scott C.B., Scarantino C., Urtasun R., Movsas B., Jones C.U., Simpson J.R., Fischbach A.J., and Curran Jr. W.J. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int. J. Radiat. Oncol. Biol. Phys. 40 (1998) 51-55
40. Shai R., Shi T., Kremen T.J., Horvath S., Liau L.M., Cloughesy T.F., Mischel P.S., and Nelson S.F. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22 (2003) 4918-4923
41. Sun L., Hui A.M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9 (2006) 287-300
42. The Cancer Genome Atlas (TCGA) Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 (2008) 1061-1068
43. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
44. Tso C.L., Freije W.A., Day A., Chen Z., Merriman B., Perlina A., Lee Y., Dia E.Q., Yoshimoto K., Mischel P.S., et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res. 66 (2006) 159-167
45. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98 (2001) 5116-5121
46. Watanabe K., Tachibana O., Sata K., Yonekawa Y., Kleihues P., and Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 6 (1996) 217-223 discussion 223-224
47. Whitfield M.L., Sherlock G., Saldanha A.J., Murray J.I., Ball C.A., Alexander K.E., Matese J.C., Perou C.M., Hurt M.M., Brown P.O., and Botstein D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13 (2002) 1977-2000
48. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G.J., et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360 (2009) 765-773
49. Zhu Y., Ghosh P., Charnay P., Burns D.K., and Parada L.F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296 (2002) 920-922